Avadel Pharma (AVDL)
18.09
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K AVADEL PHARMACEUTICALS For: Apr 15
April 15, 2024 7:01 AM - SEC Filing
Form 8-A12B AVADEL PHARMACEUTICALS
April 15, 2024 7:01 AM - SEC Filing
Here are Oppenheimer’s best Smidcap ideas
April 2, 2024 10:00 AM - StreetInsider
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
April 1, 2024 8:00 AM - Globe NewsWire
Avadel Pharmaceuticals (AVDL) PT Raised to $22 at Craig-Hallum
March 5, 2024 8:35 AM - StreetInsider
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
March 5, 2024 8:01 AM - Globe NewsWire
Avadel Pharmaceuticals (AVDL) PT Raised to $29 at Oppenheimer
March 5, 2024 7:40 AM - StreetInsider
Avadel Pharmaceuticals (AVDL) PT Raised to $22 at Needham
March 5, 2024 7:14 AM - StreetInsider
Avadel Pharmaceuticals (AVDL) PT Raised to $25 at H.C. Wainwright
March 5, 2024 6:41 AM - StreetInsider
Avadel Pharmaceuticals (AVDL) PT Raised to $23 at Piper Sandler
March 4, 2024 4:10 PM - StreetInsider
Form 8-K AVADEL PHARMACEUTICALS For: Mar 04
March 4, 2024 3:52 PM - SEC Filing
Avadel (AVDL) is pleased with jury’s decision ruling in favor of Avadel with respect to one of the contested patents
March 4, 2024 3:38 PM - StreetInsider
Avadel Pharmaceuticals Issues Statement On Patent Litigation
March 4, 2024 3:37 PM - Globe NewsWire
Avadel Pharma (AVDL) Climbs 13%
March 4, 2024 3:08 PM - StreetInsider
Form 8-K AVADEL PHARMACEUTICALS For: Mar 04
March 4, 2024 6:35 AM - SEC Filing
Avadel Pharma (AVDL) Misses Q4 EPS by 4c
March 4, 2024 6:31 AM - StreetInsider
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 4, 2024 6:30 AM - Globe NewsWire
Form 4 AVADEL PHARMACEUTICALS For: Feb 20 Filed by: Kim Richard J
March 4, 2024 6:29 AM - SEC Filing
Form 4 AVADEL PHARMACEUTICALS For: Feb 20 Filed by: MCHUGH THOMAS S
March 4, 2024 6:27 AM - SEC Filing
Form 4 AVADEL PHARMACEUTICALS For: Feb 20 Filed by: Divis Gregory J
March 4, 2024 6:24 AM - SEC Filing
Form 10-K AVADEL PHARMACEUTICALS For: Dec 31
February 29, 2024 4:44 PM - SEC Filing
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
February 26, 2024 8:00 AM - Globe NewsWire
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: RTW INVESTMENTS, LP
February 14, 2024 7:12 AM - SEC Filing
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
February 13, 2024 5:54 PM - SEC Filing
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: GENDELL JEFFREY L
February 13, 2024 4:39 PM - SEC Filing
Form SC 13G AVADEL PHARMACEUTICALS Filed by: Polar Capital Holdings Plc
February 13, 2024 9:41 AM - SEC Filing
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: KOTLER KEVIN
February 12, 2024 8:20 AM - SEC Filing
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 7, 2024 8:00 AM - Globe NewsWire
UBS Starts Avadel Pharmaceuticals (AVDL) at Buy, 'Strong Lumryz growth ahead as a differentiated product in Sleep market'
February 6, 2024 12:55 AM - StreetInsider
Full Article List
